Physician
Pathology
Dr. Lynn Moscinski, MD
|
|
Give Review
Lynn Moscinski is an expert in the field of Pathology. She studied medicine at Medical College of Wisconsin. Medical College of Wisconsin is ranked 54 in research and 62 in primary care medicine She received awards:"Regional Top Doctor". Doctor Lynn Moscinski, MD is also published. She has 82 publications published. The lastest publication: "Characterization of a unique factor-independent variant derived from human factor-dependent TF-1 cells: a transformed event.' Lynn Moscinski accepts all Medicare patients.
Publications
- Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and Acute myeloid leukemia.
- Prominent hematogone hyperplasia in BCR-ABL1-positive chronic myelogenous Leukemia: mimicking recurrent B-lymphoid blast crisis.
- Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell Lymphoma. Implications for staging and prognosis.
- Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in Large granular lymphocyte leuk...
- Bone marrow involvement as initial presentation of CD8 cytotoxic peripheral T-cell Lymphoma with CD20 coexpression and relatively indolent clinical course.
- B-Lymphoblastic Leukemia/Lymphoma Associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1 : Rare Case and Review of the Literature.
- Double-hit mantle cell Lymphoma with MYC gene rearrangement or amplification: a report of four cases and review of the literature.
- Concurrence of B-lymphoblastic Leukemia and myeloproliferative neoplasm with copy neutral loss of heterozygosity at chromosome 1p harboring a MPL W515S mutation.
- CD95 antigen mutations in hematopoietic malignancies.
- An IkappaBalpha inhibitor causes Leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism.
- CD44 expression and MMP-2 secretion by mouse glioma Cells: effect of interferon and anti-CD44 antibody.
- Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human Myeloid leukemic cell line.
- Transforming growth factor beta inhibits growth of more differentiated myeloid Leukemia cells and retinoblastoma protein phosphorylation at serine 795.
- Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma Cells.
- Characterization of a unique factor-independent variant derived from human factor-dependent TF-1 Cells: a transformed event.
- Assessment of intraCellular TAP-1 and TAP-2 in conjunction with surface MHC class I in plasma Cells from patients with multiple myeloma.
- Type III hypersensitivity reaction with the use of interferon-alpha.
- Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC-IE): a novel, intensive induction chemotherapy regimen for patients with high-risk multiple Myeloma.
- High-sensitivity detection of minimal residual breast carcinoma using the polymerase chain reaction and primers for cytokeratin 19.
- Recommendations for the use of routine bone marrow aspiration and lumbar punctures in the follow-up of patients with retinoblastoma.
- Molecular cloning of a novel Myeloid granule protein.
- Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and au...
- Urokinase plasminogen activator in ovarian cancer.
- Immunoglobulin germline mu transcripts in Acute myelogenous leukemia cells vary in splicing pattern and are heterogeneous.
- High dose versus standard dose chemotherapy for the treatment of breast cancer. A review of current concepts.
- Cyclin D1 protein expression in mantle cell Lymphoma.
- Multiple Myeloma in women with silicone breast implants. Serum immunoglobulin and interleukin-6 studies in women at risk.
- Thymosin beta 4 synergizes with human granulocyte-macrophage colony-stimulating factor in maintaining bone marrow proliferation.
- Sterile transcription of immunoglobulin/T-cell receptor genes and other evidence of early lymphoid differentiation in Acute myelogenous leukemia.
- High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple Myeloma.
- Acute lymphocytic leukemia (ALL) in elderly patients.
- Case report of spontaneous remission of cytogenetic relapse of chronic myelogenous Leukemia suggestive of progression to blast crisis after allogeneic bone marrow tran...
- Spontaneous remission in monosomy 7 myelodysplastic Syndrome.
- Non-Hodgkin's Lymphoma in the older person: a review.
- Dual role for Afipia felis and Rochalimaea henselae in cat-scratch Disease.
- Recent progress in multiple Myeloma.
- Primary eosinophilic granuloma of frontal lobe. Diagnostic use of S-100 protein.
- Pancytopenia in propionic acidemia: hematologic evaluation and studies of hematopoiesis in vitro.
- Myeloperoxidase and oncogene expression in GM-CSF induced bone marrow differentiation.
- Myeloperoxidase-positive Acute megakaryoblastic leukemia.
- A case of the eosinophilia-myalgia Syndrome associated with use of an L-tryptophan product.
- Identification of a series of differentiation-associated gene sequences from GM-CSF stimulated bone marrow.
- Surface marker analysis and karyotype distinguish Acute biphenotypic leukemia from Acute myelogenous leukemia expressing terminal deoxynucleotidyl transferase.
- Sequence homology of deoxyribonucleic acid to mouse mammary tumor virus genome in human breast tumors.
- The significance of an elevated serum lysozyme value in Acute myelogenous leukemia with eosinophilia.
- Acute myelogenous leukemia in the elderly.
- Pure red Cell aplasia: treatment with intravenous immunoglobulin concentrate.
- Treatment of deletion 5q Acute myeloid leukemia with lenalidomide.
- TGFbeta inhibits GM-CSF-induced phosphorylation of ERK and MEK in human Myeloid leukaemia cell lines via inhibition of phosphatidylinositol 3-kinase (PI3-k).
- Lymphoma cell adhesion-induced expression of B cell-activating factor of the TNF family in bone marrow stromal cells protects non-Hodgkin''s B Lymphoma cells from apop...
- Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin''s B-cell Lymphomas.
- Cdc2: a monopotent or pluripotent CDK?
- Bone marrow stromal cells prevent apoptosis of Lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodg...
- Nonnecrobiotic necrobiotic xanthogranuloma as an initial manifestation of paraproteinemia and small lymphocytic lymphoma in a patient with Sjögren Syndrome.
- Cutaneous manifestations in CMML: Indication of Disease acceleration or transformation to AML and review of the literature.
- TGFbeta regulates the expression and activities of G2 checkpoint kinases in human myeloid Leukemia cells.
- Reduced natural killer (NK) function associated with high-risk myelodysplastic Syndrome (MDS) and reduced expression of activating NK receptors.
- Phenytoin-associated lymphoadenopathy mimicking a peripheral T-cell Lymphoma.
- Identification of a risk dependent microRNA expression signature in myelodysplastic Syndromes.
- A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous Leukemia treated with tyrosine kinase inhibitors.
- Uncommon of the uncommon: low-grade myelodysplastic syndrome evolving into chronic myelogenous Leukemia.
- Follicular dendritic cell-dependent drug resistance of non-Hodgkin Lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a.
- Mixed phenotype Acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
- microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell Lymphoma.
- Immunomodulatory derivatives induce PU.1 down-regulation, Myeloid maturation arrest, and neutropenia.
- Modulation of hyaluronan production by CD44 positive glioma Cells.
- Leptomeningeal Myeloma as the sole manifestation of relapse: an unusual presentation.
- Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte Leukemia associated with imbalanced NK receptor signaling.
- Cell adhesion induces p27Kip1-associated Cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-Cell and other non-Hodgkin B-Cell ...
- "Virtual flow cytometry" of immunostained lymphocytes on microscopic tissue slides: iHCFlow tissue cytometry.
- beta2 Integrins are characteristically absent in Acute promyelocytic leukemia and rapidly upregulated in vivo upon differentiation with all-trans retinoic acid.
- Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC Cells and AML Cells with activating mutati...
- Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human Acute myelogenous leukemia cells with ...
- Value of positron emission tomography scan in staging cancers, and an unusual presentation of Acute myeloid leukemia. Case 3. Acute myeloid leukemia presenting with ly...
- Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human Acute myelogenous leukemia cells with mutant F...
- Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex ...
- Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma Cell line model.
- Development of CD30+ lymphoproliferative Disease in mice lacking interferon regulatory factor-1.
- Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -re...
- Acute myeloid leukemia mimicking primary testicular neoplasm. Presentation of a case with review of literature.
- Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML Cells.
Schools
Medical College of Wisconsin
University Colo Health Science Center
University Of Pennsylvania
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
- Hematopathology
- Pathology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
University of Pennsylvania Health System -
University of Colorado -
Medical College of Wisconsin
Hospital
-
H. Lee Moffitt Cancer Center and Research Institute
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962422485 |
| Last Name Of The Provider | MOSCINSKI |
| First Name Of The Provider | LYNN |
| View All |
Similar Doctors
|
Dr. Shohreh I. Iravani, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce O. Hough, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Domenico Coppola, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amr S. Khaled, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vita P. Saranga-Perry, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Dahui Qin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen Mastorides, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jianguo Tao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sabiha R. Saba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maheswari Vinaitheerthan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Markow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Panagiotis Pantazopoulos, MD
This Doctor is OpenDoctor Recommended.
|